No Data
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
B of A Securities Downgrades Zai Lab to Neutral, Raises Price Target to $36.1
Zai Lab Analyst Ratings
Earnings Call Summary | Zai Lab(ZLAB.US) Q4 2024 Earnings Conference
Earnings Scheduled For February 27, 2025
The wave of AI in Medical is sweeping: the potential of the macromolecule new drug market is highlighted and imaging products are "going overseas" into Emerging Markets | Focus
① Some executives from pharmaceutical companies have stated that "currently, the discovery of small molecule drugs is very challenging; finding potential molecules and structures is already quite difficult, while there is still significant potential in the discovery and design of large molecule new drugs." ② Currently, the application maturity of AI technology in the imaging field is relatively high, and relevant manufacturers have revealed that the market potential for AI imaging large models in Belt and Road Initiative Concept countries is quite extensive.